3,343,861 Shares in MiMedx Group, Inc. (NASDAQ:MDXG) Bought by First Light Asset Management LLC

First Light Asset Management LLC purchased a new stake in MiMedx Group, Inc. (NASDAQ:MDXG - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 3,343,861 shares of the company's stock, valued at approximately $32,168,000. MiMedx Group accounts for about 3.1% of First Light Asset Management LLC's investment portfolio, making the stock its 14th largest holding. First Light Asset Management LLC owned approximately 2.28% of MiMedx Group at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the business. Norges Bank bought a new stake in MiMedx Group during the 4th quarter worth approximately $4,020,000. JPMorgan Chase & Co. grew its position in shares of MiMedx Group by 133.1% during the 4th quarter. JPMorgan Chase & Co. now owns 693,106 shares of the company's stock valued at $6,668,000 after purchasing an additional 395,739 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in shares of MiMedx Group by 484.2% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 362,481 shares of the company's stock worth $3,487,000 after purchasing an additional 300,433 shares during the period. Renaissance Technologies LLC raised its position in shares of MiMedx Group by 18.4% in the fourth quarter. Renaissance Technologies LLC now owns 1,804,557 shares of the company's stock worth $17,360,000 after buying an additional 280,327 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in MiMedx Group by 15.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,802,364 shares of the company's stock valued at $17,338,000 after buying an additional 238,075 shares during the period. 79.15% of the stock is currently owned by hedge funds and other institutional investors.

MiMedx Group Price Performance

NASDAQ:MDXG traded down $0.56 during mid-day trading on Thursday, reaching $6.32. The stock had a trading volume of 1,510,254 shares, compared to its average volume of 679,036. The stock has a market capitalization of $931.35 million, a P/E ratio of 11.49 and a beta of 1.74. The firm has a 50 day moving average price of $7.47 and a two-hundred day moving average price of $8.07. The company has a debt-to-equity ratio of 0.10, a quick ratio of 3.53 and a current ratio of 4.10. MiMedx Group, Inc. has a one year low of $5.47 and a one year high of $10.14.

MiMedx Group (NASDAQ:MDXG - Get Free Report) last announced its quarterly earnings data on Wednesday, April 30th. The company reported $0.06 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.06. MiMedx Group had a net margin of 23.86% and a return on equity of 26.21%. The company had revenue of $88.21 million during the quarter, compared to analysts' expectations of $86.32 million. As a group, analysts expect that MiMedx Group, Inc. will post 0.3 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on MDXG shares. StockNews.com cut shares of MiMedx Group from a "strong-buy" rating to a "buy" rating in a research report on Wednesday, April 16th. Cantor Fitzgerald restated an "overweight" rating and set a $13.00 price objective on shares of MiMedx Group in a research report on Thursday, February 27th.

Insider Transactions at MiMedx Group

In other MiMedx Group news, insider Kimberly Maersk-Moller sold 4,106 shares of the stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $7.89, for a total transaction of $32,396.34. Following the completion of the sale, the insider now owns 310,836 shares of the company's stock, valued at $2,452,496.04. This represents a 1.30 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO William Frank Iv Hulse sold 81,446 shares of the business's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $7.80, for a total transaction of $635,278.80. Following the completion of the transaction, the chief accounting officer now owns 494,774 shares in the company, valued at $3,859,237.20. The trade was a 14.13 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 144,018 shares of company stock worth $1,130,312. Company insiders own 1.30% of the company's stock.

MiMedx Group Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins.